Abnova Introduces Advanced miRNA Probe Customization Services and Catalog Products, Revitalizing the Field of miRNA Research

 

Neihu, Taiwan (September 18, 2023)

 

Abnova announced the launch of its advanced miRNA probe customization services and a brand-new catalog of miRNA probes, catering to the needs of the academic, industrial, and research communities engaged in miRNA research. Abnova's highly efficient and precise miRNA probe catalog covers several targets related to the field of cancer, offering researchers the specialized tools necessary for in-depth exploration of miRNA expression and regulation.

 

miRNA, or microRNA, refers to small non-coding RNA molecules typically ranging from 21 to 25 nucleotides in length. Within biological specimens, miRNA probes are indispensable for the identification and precise localization of miRNAs. These miRNA probes find widespread applications in various life science domains, including gene regulation, functional analysis, miRNA expression studies, the discovery of diagnostic biomarkers, and drug development. To cater to diverse research requirements within the academic and industrial sectors, Abnova offers customized miRNA probe services, providing greater flexibility and versatility.

 

Abnova's miRNA probe customization services are characterized by high specificity and minimal cross-reactivity, making them particularly suitable for analyzing samples with limited miRNA content, such as cells, frozen tissues, or formalin-fixed paraffin-embedded tissue samples (FFPE). MiRNA probes not only enable the visualization of the spatial distribution of specific miRNAs but also allow for semi-quantitative measurement of miRNA expression levels. Furthermore, Abnova has expanded its catalog products to include tumor-related miRNA probe catalog items, which exhibit high sensitivity and are valuable tools for detecting low-concentration miRNAs, serving as powerful instruments for miRNA biomarker detection.

 

Abnova is committed to continuously providing cutting-edge miRNA probes to support miRNA research and diagnostics, driving the ongoing evolution of miRNA-related investigations. The innovative products and customization services for miRNA probes will open up new possibilities for the academic, industrial, and research communities, ushering in a new chapter in miRNA research.

 

For detailed information, please visit Abnova's miRNA probe customization service at:

https://www.abnova.com/en-global/services/mirna_probes

 

Abnova's miRNA probe catalog products can be found at:

https://www.abnova.com/en-global/product/filter?application=140&category=AAABAC000000

Abnova

+886-2-87511888

sales@abnova.com

Abnova has established a comprehensive portfolio of fully integrated solutions to address the needs of the in vitro diagnostic (IVD) industry. Abnova provides its partners and customers access to the technologies, products, and services relating to circulating rare cells, circulating exosomes, and circulating cell-free RNA for early to metastatic to recurrent disease and treatment diagnosis, prediction, guidance, and monitoring. Abnova facility is for proprietary bioreagent and high-throughput automation development and manufacturing for clinical trials and IVD commercialization. (www.abnova.com)